Skip to Main Content

Paper Details

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.
Genet Med
327
2020
Cancer, Lynch Syndrome, Lynch syndrome, MLH1, MSH2, MSH2 variants, MSH6, MSH6 variants, PMS2, PMS2 variants, cancer, cancers, cancers of the upper urinary tract, colon, endometrial, or ovarian cancer, colorectal cancer, colorectal, endometrial, and ovarian cancer, dominant cancer syndromes, endometrial cancer, mismatch, participants, pathogenic PMS2 variants
Author NameAffiliation
Sigve NakkenInstitute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital
David J BurnInstitute of Genetic Medicine, Newcastle University
Eivind HovigInstitute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital
Eivind HovigInstitute of Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital
Robert W HaileStanford Cancer Institute, Stanford University
Noralane M LindorMayo Clinic Arizona
Noralane M LindorMayo Clinic Arizona
Steven GallingerLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Loic Le MarchandUniversity of Hawaii Cancer Center
Stephen N ThibodeauMayo Clinic
  • 1 - 10

Datasets

Release 1.2